/ RecruitingNot Applicable [Translation] Study on the bioequivalence of metoprolol succinate sustained-release tablets in healthy volunteers
在中国健康成年受试者中,比较单次口服琥珀酸美托洛尔缓释片(佛山德芮可制药有限公司)与倍他乐克缓释片(阿斯特利康公司)的药代动力学的特征,评价其药代动力学的等效性。并评价单次口服琥珀酸美托洛尔缓释片(佛山德芮可制药有限公司)与倍他乐克缓释片(阿斯特利康公司)的安全性特征的差异。
[Translation] To compare the pharmacokinetic characteristics of a single oral dose of metoprolol succinate sustained-release tablets (Foshan De Rui Ke Pharmaceutical Co., Ltd.) and Betaloc sustained-release tablets (Astrizeneca) in healthy Chinese adult subjects, and evaluate their pharmacokinetic equivalence. The difference in safety characteristics of a single oral dose of metoprolol succinate sustained-release tablets (Foshan De Rui Ke Pharmaceutical Co., Ltd.) and Betaloc sustained-release tablets (Astrizeneca) was also evaluated.
100 Clinical Results associated with Foshan Dereco Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Foshan Dereco Pharmaceutical Co., Ltd.
100 Deals associated with Foshan Dereco Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Foshan Dereco Pharmaceutical Co., Ltd.